Asian Venture Capital Journal (AVCJ)
Top stories
KKR to buy control of Indian pharma player
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.
China data storage provider XSKY raises $45m
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
China's CF PharmTech raises $50m Series F
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
News continued
Analysis
LP interview: FMO
Dutch impact investor FMO has maintained significant appetite for private equity and developing Asia with relatively few resources at its disposal. Fintech is the next frontier
Interviews
LP interview: FMO
Dutch impact investor FMO has maintained significant appetite for private equity and developing Asia with relatively few resources at its disposal. Fintech is the next frontier
Profile: Kejora Ventures' Sebastian Togelang
Frustrated with his business, Sebastian Togelang returned to Indonesia from Germany to invest in technology start-ups. He counsels entrepreneurs that it pays to be part of a larger platform
People
KIC's private equity head to lead alternatives
Korea Investment Corporation (KIC) has promoted Jong-ho Kim from head of private equity to deputy CIO with a brief to lead its alternative investment group.
CDC appoints Nepal head
UK development finance institution CDC Group has appointed Rabi Rayamajhi as its first country representative for Nepal.
